AGL (agilon health, inc.)
Insider Trading Activity
Every open-market purchase and sale reported by AGL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Timothy Gertsch | Chief Accounting Officer | F | — | — |
| 2026-08-04 | Denise Zamore | Chief Legal Officer | F | — | — |
| 2026-07-02 | Jeffrey A. Schwaneke | Chief Financial Officer | F | — | — |
| 2026-06-05 | Denise Zamore | Chief Legal Officer | F | — | — |
| 2026-06-04 | John William Wulf | Director | A | — | — |
| 2026-06-04 | Silvana Battaglia | Director | A | — | — |
| 2026-06-04 | Karen McLoughlin | Director | A | — | — |
| 2026-06-04 | DIANA MCKENZIE | Director | A | — | — |
| 2026-06-04 | RONALD A WILLIAMS | Director | A | — | — |
| 2026-06-04 | Sharad Mansukani | Director | A | — | — |
| 2026-05-27 | Timothy Gertsch | Chief Accounting Officer | F | — | — |
| 2026-05-11 | Timothy Patrick O'Rourke | CEO & President | A | — | — |
| 2026-04-16 | Timothy Gertsch | Chief Accounting Officer | F | — | — |
| 2026-04-16 | Benjamin Shaker | Chief Markets Officer | F | — | — |
| 2026-04-16 | Denise Zamore | Chief Legal Officer | F | — | — |
| 2026-04-16 | Girish Venkatachaliah | Chief Technology Officer | F | — | — |
| 2026-04-03 | Jeffrey A. Schwaneke | Chief Financial Officer | MIXED | — | — |
| 2026-04-03 | Girish Venkatachaliah | Chief Technology Officer | MIXED | — | — |
| 2026-04-03 | Denise Zamore | Chief Legal Officer | MIXED | — | — |
| 2026-04-03 | Timothy Gertsch | Chief Accounting Officer | MIXED | — | — |
| 2026-04-03 | Benjamin Shaker | Chief Markets Officer | MIXED | — | — |
| 2026-03-11 | Denise Zamore | Chief Legal Officer | MIXED | — | — |
| 2026-03-11 | Benjamin Shaker | Chief Markets Officer | MIXED | — | — |
| 2026-03-11 | Girish Venkatachaliah | Chief Technology Officer | MIXED | — | — |
| 2026-03-03 | Benjamin Shaker | Chief Markets Officer | Buy | — | — |
| 2026-01-30 | John William Wulf | Director | Buy | — | — |
| 2026-01-13 | Jeffrey A. Schwaneke | Chief Financial Officer | A | — | — |
| 2025-08-19 | Timothy Gertsch | Chief Accounting Officer | F | — | — |
| 2025-08-05 | Denise Zamore | Chief Legal Officer | F | — | — |
| 2025-07-03 | Jeffrey A. Schwaneke | Chief Financial Officer | F | — | — |
| 2025-05-30 | RONALD A WILLIAMS | Director | A | — | — |
| 2025-05-30 | Karen McLoughlin | Director | A | — | — |
| 2025-05-30 | DIANA MCKENZIE | Director | A | — | — |
| 2025-05-30 | Jeffrey A. Schwaneke | Chief Financial Officer | F | — | — |
| 2025-05-30 | Silvana Battaglia | Director | A | — | — |
| 2025-05-30 | Sharad Mansukani | Director | A | — | — |
| 2025-05-30 | John William Wulf | Director | A | — | — |
| 2025-05-28 | Timothy Gertsch | Chief Accounting Officer | F | — | — |
| 2025-04-16 | Timothy Gertsch | Chief Accounting Officer | F | — | — |
| 2025-04-16 | Steven Sell | CEO & President | F | — | — |
| 2025-04-16 | Girish Venkatachaliah | Chief Technology Officer | F | — | — |
| 2025-04-16 | Benjamin Shaker | Chief Markets Officer | F | — | — |
| 2025-04-16 | Denise Zamore | Chief Legal Officer | F | — | — |
| 2025-04-03 | Timothy Gertsch | Chief Accounting Officer | A | — | — |
| 2025-04-03 | Benjamin Shaker | Chief Markets Officer | A | — | — |
| 2025-04-03 | Jeffrey A. Schwaneke | Chief Financial Officer | MIXED | — | — |
| 2025-04-03 | Steven Sell | CEO & President | A | — | — |
| 2025-04-03 | Girish Venkatachaliah | Chief Technology Officer | A | — | — |
| 2025-04-03 | Denise Zamore | Chief Legal Officer | A | — | — |
| 2025-03-18 | Girish Venkatachaliah | Chief Technology Officer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 8,237,952 | — |
| — | 10%+ Owner | 4,000,000 | — |
| — | CEO & President | 320,000 | — |
| — | Director | 149,141 | — |
| — | Chief Financial Officer | 138,923 | — |
| — | Chief Markets Officer | 122,850 | — |
| — | Chief Legal Officer | 66,075 | — |
| — | Director | 56,242 | — |
| — | CEO & President | 38,659 | — |
| — | Chief Technology Officer | 38,566 | — |
| — | Chief Strategy & Dev. Officer | 19,921 | — |
| — | Director | 16,765 | — |
| — | Chief Accounting Officer | 14,152 | — |
| — | Director | 8,207 | — |
| — | Director | 7,926 | — |
| — | Director | 7,633 | — |
| — | Director | 6,525 | — |
| — | Director | 4,800 | — |
| — | Chief Med. & Quality Officer | 2,482 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AGL quote page; the site-wide leaderboard is on the insider transactions hub.